Primaquine for Prevention of Malaria in Travelers

Clinical Infectious Diseases

Volumn 37, Issue 12, 2003, Pages 1659-1667

  Baird, J Kevin ^a   Fryauff, David J ^b   Hoffman, Stephen L ^c  

^a California   (United States)

^b NAVAL MEDICAL RESEARCH CENTER   (United States)

^c SANARIA INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; DOXYCYCLINE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; MEFLOQUINE; METHEMOGLOBIN; PRIMAQUINE;

ABDOMINAL PAIN; ANTIMALARIAL ACTIVITY; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CYANOSIS; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; DYSPNEA; GASTROINTESTINAL SYMPTOM; HUMAN; MALARIA; MALARIA CONTROL; METHEMOGLOBINEMIA; NAUSEA; NEUROTOXICITY; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PRIORITY JOURNAL; REVIEW; VOMITING;

ADULT; ANIMALS; ANTIMALARIALS; CHEMOPREVENTION; CLINICAL TRIALS; DRUG TOLERANCE; HUMANS; MALARIA, FALCIPARUM; MALARIA, VIVAX; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PRIMAQUINE; TRAVEL;

EID: 0346848721     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/379714     Document Type: Review

References (43)

1. Campbell CC. Malaria: an emerging and re-emerging global plague. FEMS Immunol Med Microbiol 1997; 18:325-31.
2. Baird JK. Malaria at the millennium: control strategies in crisis. Drugs 2000; 59:719-43.
3. Schapiro TA, Ranasinha CD, Kumar N, Barditch-Crovo P. Prophylactic activity of atovaquone against Plasmodium falciparum in humans. Am J Trop Med Hyg 1999; 60:831-6.
4. Shanks GD, Kremsner PG, Sukwa TY, et al. Atovaquone and proguanil hydrochloride for prophylaxis of malaria. J Travel Med 1999; 6(Suppl): S21-7.
5. Arnold J, Alving AS, Hockwald RS, et al. The effect of continuous and intermittent primaquine therapy on the relapse rate of Chesson strain vivax malaria. J Lab Clin Med 1954; 44:429-38.
6. Arnold J, Alving AS, Hockwald RS, et al. The antimalarial action of primaquine against the blood and tissue stages of falciparum malaria. J Lab Clin Med 1955; 46:391-7.
7. Peters W. Chemotherapy and drug resistance. London: Academic Press, 1987.
8. Fisher GU, Gordon MP, Lobel HO, Runcik K. Malaria in soldiers returning from Vietnam: epidemiologic, therapeutic and clinical studies. Am J Trop Med Hyg 1970; 19:27-39.
9. Baird JK, Fryauff DJ, Basri H, et al. Primaquine for prophylaxis against malaria among nonimmune transmigrants in Irian Jaya, Indonesia. Am J Trop Med Hyg 1995; 52:479-84.
10. Weiss WR, Oloo AJ, Johnson A, Koech D, Hoffman SL. Daily primaquine is effective for prophylaxis against falciparum malaria in Kenya: comparison with mefloquine, doxycycline, and chloroquine plus proguanil. J Infect Dis 1995; 171:1569-75.
11. Fryauff DJ, Baird JK, Basri H, et al. Randomized, placebo-controlled trial of primaquine for prophylaxis of falciparum and vivax malaria in Indonesia. Lancet 1995; 346:1190-3.
12. Soto J, Toledo J, Rodriquez M, et al. Primaquine prophylaxis against malaria in nonimmune Colombian soldiers: efficacy and toxicity. Ann Intern Med 1998; 129:241-4.
13. Schwartz E, Regev-Yochay G. Primaquine as prophylaxis for malaria in nonimmune travelers: a comparison with mefloquine and doxycycline. Clin Infect Dis 1999; 29:1502-6.
14. Baird JK, Lacy MD, Basri H, et al. Randomized, parallel placebo-controlled trial of primaquine for malaria prophylaxis in Papua, Indonesia. US NAMRU-2 Clinical Trials Team. Clin Infect Dis 2001; 33: 1990-7.
15. Pukrittayakamee S, Vanijononta S, Chantra A, Clemens R, White NJ. Blood stage antimalarial efficacy of primaquine in Plasmodium vivax malaria. J Infect Dis 1994; 169:932-5.
16. Geary TG, Divo AA, Jenson JB. Activity of quinoline antimalarials against chloroquine-sensitive and -resistant strains of Plasmodium falciparum in vitro. Trans Roy Soc Trop Med Hyg 1987; 81:499-503.
17. Baird JK, Wiady I, Sutanihardja A, et al. Short report: therapeutic efficacy of chloroquine combined with primaquine against Plasmodium falciparum in northeastern Papua, Indonesia. Am J Trop Med Hyg 2002; 66:659-60.
18. World Health Organization (WHO). The use of antimalarial drugs. WHO/CDS/RBM/2001.3. Geneva: WHO, 2001.
19. Brueckner RP, Ohrt C, Baird JK, Milhous WK. 8-Aminoquinolines. In: Rosenthal PJ, ed. Antimalarial chemotherapy: mechanisms of action, resistance and new directions in drug discovery. Totowa, NJ: Humana Press, 2001:123-51.
20. Grewal RS. Pharmacology of 8-aminoquinolines. Bull WHO 1981; 59: 397-406.
21. Fletcher KA, Barton PF, Kelly JA. Studies on the mechanisms of oxidation in the erythrocyte by metabolites of primaquine. Biochem Pharmacol 1988; 37:2683-90.
22. Boulard Y, Landau I, Milgen F, Ellis DS, Peters W. The chemotherapy of rodent malaria, XXXIV. Causal prophylaxis. Part III: ultrastructural changes induced in exo-erythrocytic schizonts of Plasmodium yoelii yoelii by primaquine. Ann Trop Med Parasitol 1983; 77:555-68.
23. Warhurst DC. Why are primaquine and other 8-aminoquinolines particularly effective against the mature gametocytes and the hypnozoites of malaria? Ann Trop Med Parasitol 1984; 78:165.
24. Schmidt LH, Fradkin R, Vaughan D, Rasco J. Radical cure of infections with Plasmodium cynomolgi: a function of total 8-aminoquinoline dose. Am J Trop Med Hyg 1977; 26:1116-28.
25. Clyde DF, McCarthy VE. Radical cure of Chesson strain vivax malaria in man by 7, not 14, days of treatment with primaquine. Am J Trop Med Hyg 1977; 26:562-3.
26. Alving AS, Johnson CF, Tarlov AR, Brewer GJ, Kellermeyer RW, Carson PE. Mitigation of the hemolytic effect of primaquine and enhancement of its action against exoerythrocytic forms of the Chesson strain of Plasmodium vivax by intermittent regimens of drug administration. Bull World Health Organ 1960; 22:621-31.
27. Powell RD, Brewer GJ. The effects of pyrimethamine, chloroquine and primaquine against exoerythrocytic forms of a strain of chloroquine-resistant Plasmodium falciparum from Thailand. Am J Trop Med Hyg 1967; 16:693-8.
28. Alving AS, Rucker K, Flanagan CL, et al. Observations on primaquine in the prophylaxis and cure of vivax malaria. In: Proceedings of the 6th International Congress of Tropical Medicine and Malaria 1959; 7: 203-9.
29. Vivona S, Brewer GJ, Conrad M, Alving AS. The concurrent weekly administration of chloroquine and primaquine for the prevention of Korean vivax malaria. Bull World Health Organ 1961; 25:267-9.
30. Hoffman SL. Prevention of malaria. JAMA 1991; 265:398-9.
31. Ling J, Baird JK, Fryauff DJ, et al. Randomized, placebo-controlled trial of atovaquone/proguanil for prevention of Plasmodium falciparum or Plasmodium vivax among migrants to Papua, Indonesia. Clin Infect Dis 2002; 35:825-33.
32. Carson PE, Hohl R, Nora MV, et al. Toxicology of the 8-aminoquinolines and genetic factors associated with their toxicity in man. Bull World Health Organ 1981; 59:427-37.
33. Clyde DF. Clinical problems associated with the use of primaquine as a tissue schizonticidal and gametocytocidal drug. Bull World Health Organ 1981; 59:391-5.
34. Clayman CB, Arnold J, Hochwald RS, Yount EH, Edgcomb JH, Alving AS. Toxicity of primaquine in Caucasians. JAMA 1952; 149:1563-8.
35. Fletcher KA, Evans-Price DA, Giles HM, et al. Studies on the pharmacokinetics of primaquine. Bull World Health Organ 1981; 59:407.
36. Coleman MD, Coleman NA. Drug-induced methaemoglobinaemia: treatment issues. Drug Safety 1996; 14:394.
37. Cohen RJ, Sachs JR, Wicker DJ, Conrad ME. Methemoglobinemia provoked by malarial chemoprophylaxis in Vietnam. N Engl J Med 1968; 279:1127-31.
38. Beutler E. G6PD deficiency. Blood 1994; 84:3613-36.
39. Karwacki JJ, Shanks GD, Kummalue T, Watanasook C. Primaquine induced hemolysis in a Thai soldier. Southeast Asian J Trop Med Public Health 1989; 20:555-6.
40. Sarkar S, Prakash D, Marwaha RK, et al. Acute intravascular hemolysis in glucose-6-phosphate dehydrogenase deficiency. Ann Trop Paediatr 1993; 13:391-4.
41. Salvidio E, Pannacciulli I, Tizianello A, Aimar F. Nature of hemolytic crises and the fate of G6PD deficient drug-damaged erythrocytes in Sardinians. N Engl J Med 1967; 276:1339-44.
42. George JN, Sears DA, McCurdy P, Conrad ME. Primaquine sensitivity in Caucasians: hemolytic reactions induced by primaquine in G6PD deficient subjects. J Lab Clin Med 1967; 70:80-93.
43. Baird JK. Brief exposure malaria prevention. In: Schlagenhauf P, ed. Traveler's malaria. London: BC Decker, 2001:270-6.